Article Text


Misoprostol does not alter the pharmacokinetics of propranolol.
  1. P. N. Bennett,
  2. G. C. Fenn,
  3. L. J. Notarianni,
  4. C. E. Lee
  1. Clinical Pharmacology Unit, Royal United Hospital, Combe Park, Bath, UK.


    Twelve healthy volunteers took part in a randomised, double-blind, balanced, cross-over study to investigate the effect of misoprostol on the pharmacokinetics of propranolol. The subjects took propranolol 80 mg twice daily by mouth plus either misoprostol 400 micrograms twice daily or placebo by mouth for 14.5 days, followed by a 2-week washout period, followed by the alternate treatment for 14.5 days. Misoprostol had no significant effect on the t/2, Cmax or AUC of propranolol either after a single dose or at steady state.

    Statistics from

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.